Last reviewed · How we verify
NCT06683859
Variants of Paranasal Sinuses in Nepali Population
trial in Paranasal Sinuses in 360 participants. Completed in 5 November 2024.
1 November 2024
Quick facts
| Lead sponsor | Grande International Hospital, Nepal |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 360 |
| Start date | 1 April 2022 |
| Primary completion | 1 November 2024 |
| Estimated completion | 5 November 2024 |
| Sites | 1 location across Nepal |
Conditions studied
- Paranasal Sinuses — all drugs for Paranasal Sinuses →
Sponsor
Grande International Hospital, Nepal
Who can join
13 and older, any sex, with Paranasal Sinuses. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The variants of paranasal sinuses (PNS)and nasal cavity are of clinical importance since some variants are susceptible to recurrent infection. Moreover, during functional endoscopic sinus surgery, knowledge of anatomy is of utmost importance in order to prevent injury of vital structures like optic nerves, carotid arteries etc. However, there is lack of study enrolling adequate number of patients in our country. Critical variants are often underreported by radiologists. Thus, it is imperative to know true prevalence of different anatomical variants.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Critical anatomical variants in preoperative computed tomography of paranasal sinuses in a tertiary care center: a cross-sectional study.
Dahal P, Parajuli S, Maharjan S, Adhikari G, et al · · 2025 · cited 2× · PMID 40212226 · DOI 10.1097/ms9.0000000000003116
Verify or expand the search:
- PubMed search for NCT06683859
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Paranasal Sinuses
Currently open trials in the same condition.
- NCT05027633 — Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-N · Phase 2 · recruiting
Other Grande International Hospital, Nepal trials
Trials by the same sponsor.
- NCT06751420 — Circle of Willis Variants in Nepali Population Evaluated in TOF MR Angiography · completed
- NCT06434675 — Prevalence of Variants of Nasal Cavity and Nasal Septum in Nepalese · completed
- NCT06793007 — Variants Of Intrahepatic Biliary Radicals in Nepali Population · completed
- NCT06077929 — Optic Nerve Course Variants in Nepali Population · completed
- NCT06251440 — Initial Experience of Transabdominal Fetal Reduction in Nepal · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06683859 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Grande International Hospital, Nepal
- Last refreshed: 12 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06683859.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing